MedPath

海南广升誉制药有限公司

Ownership
-
Established
2016-01-18
Employees
-
Market Cap
-
Website
www.hnjcjk.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

80

NMPA:80

Drug Approvals

Nicardipine Hydrochloride Injection

Product Name
盐酸尼卡地平注射液
Approval Number
国药准字H20254028
Approval Date
Apr 30, 2025
NMPA

Loxoprofen Sodium Oral Solution

Product Name
洛索洛芬钠口服溶液
Approval Number
国药准字H20254023
Approval Date
Apr 30, 2025
NMPA

Nicardipine Hydrochloride Injection

Product Name
盐酸尼卡地平注射液
Approval Number
国药准字H20254027
Approval Date
Apr 30, 2025
NMPA

Minoxidil Liniment

Product Name
米诺地尔搽剂
Approval Number
国药准字H20253509
Approval Date
Mar 4, 2025
NMPA

Minoxidil Liniment

Product Name
米诺地尔搽剂
Approval Number
国药准字H20253510
Approval Date
Mar 4, 2025
NMPA

Cefadroxil Tablets

Product Name
头孢羟氨苄片
Approval Number
国药准字H20253136
Approval Date
Jan 14, 2025
NMPA

Cefadroxil Tablets

Product Name
头孢羟氨苄片
Approval Number
国药准字H20253137
Approval Date
Jan 14, 2025
NMPA

Omeprazole and Sodium Bicarbonate Capsules

Product Name
奥美拉唑碳酸氢钠胶囊
Approval Number
国药准字H20249803
Approval Date
Dec 25, 2024
NMPA

Omeprazole and Sodium Bicarbonate Capsules(Ⅱ)

Product Name
奥美拉唑碳酸氢钠胶囊(Ⅱ)
Approval Number
国药准字H20249804
Approval Date
Dec 25, 2024
NMPA

Amoxicillin Sodium for Injection

Product Name
注射用阿莫西林钠
Approval Number
国药准字H20249018
Approval Date
Oct 9, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 8
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.